Russell Investments Group, Ltd. Innoviva, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 361,823 shares of INVA stock, worth $6.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

361,823

Previous 516,288 29.92%

Holding current value

$6.96 Million

Previous $8.47 Million 17.53%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$16.33 - $20.04 $2.52 Million - $3.1 Million	-154,465 Reduced 29.92%	361,823 $6.98 Million
Q2 2024 Aug 08, 2024	SELL	$14.4 - $16.4 $635,846 - $724,158	-44,156 Reduced 7.88%	516,288 $8.47 Million
Q1 2024 May 08, 2024	SELL	$14.56 - $16.78 $4.5 Million - $5.18 Million	-308,894 Reduced 35.53%	560,444 $8.54 Million
Q4 2023 Feb 05, 2024	SELL	$12.32 - $16.27 $5.22 Million - $6.89 Million	-423,347 Reduced 32.75%	869,338 $13.9 Million
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $913,945 - $1.03 Million	-73,884 Reduced 5.41%	1,292,685 $16.8 Million
Q2 2023 Aug 10, 2023	BUY	$11.39 - $13.72 $10 Million - $12.1 Million	878,957 Added 180.26%	1,366,569 $17.4 Million
Q1 2023 May 09, 2023	BUY	$10.73 - $13.6 $232,325 - $294,467	21,652 Added 4.65%	487,612 $5.49 Million
Q4 2022 Feb 08, 2023	BUY	$11.8 - $13.78 $1.6 Million - $1.87 Million	135,489 Added 41.0%	465,960 $6.17 Million
Q3 2022 Nov 04, 2022	BUY	$11.61 - $15.22 $113,069 - $148,227	9,739 Added 3.04%	330,471 $3.84 Million
Q2 2022 Jul 29, 2022	BUY	$14.32 - $19.88 $3.54 Million - $4.92 Million	247,369 Added 337.18%	320,732 $4.73 Million
Q1 2022 May 05, 2022	BUY	$15.39 - $20.25 $242,869 - $319,565	15,781 Added 27.41%	73,363 $1.42 Million
Q4 2021 Jan 21, 2022	SELL	$15.91 - $18.72 $3.32 Million - $3.9 Million	-208,385 Reduced 78.35%	57,582 $992,000
Q3 2021 Nov 08, 2021	BUY	$13.06 - $17.24 $2.43 Million - $3.21 Million	186,412 Added 234.32%	265,967 $4.44 Million
Q2 2021 Aug 04, 2021	SELL	$11.45 - $13.96 $1.39 Million - $1.69 Million	-121,118 Reduced 60.36%	79,555 $1.07 Million
Q1 2021 May 10, 2021	BUY	$11.06 - $12.87 $1.78 Million - $2.07 Million	161,204 Added 408.43%	200,673 $2.4 Million
Q4 2020 Feb 08, 2021	BUY	$9.33 - $12.48 $138,307 - $185,003	14,824 Added 60.15%	39,469 $486,000
Q3 2020 Nov 09, 2020	SELL	$10.33 - $14.49 $513,473 - $720,254	-49,707 Reduced 66.85%	24,645 $257,000
Q2 2020 Aug 05, 2020	BUY	$11.49 - $15.26 $133,881 - $177,809	11,652 Added 18.58%	74,352 $1.04 Million
Q1 2020 May 06, 2020	BUY	$8.11 - $15.23 $508,496 - $954,921	62,700 New	62,700 $737,000
Q3 2019 Nov 01, 2019	SELL	$10.05 - $14.55 $38,210 - $55,319	-3,802 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$13.1 - $14.95 $115,856 - $132,217	-8,844 Reduced 69.94%	3,802 $55,000
Q1 2019 May 13, 2019	SELL	$13.69 - $20.06 $1.74 Million - $2.55 Million	-127,280 Reduced 90.96%	12,646 $177,000
Q4 2018 Feb 11, 2019	BUY	$13.96 - $18.26 $1.25 Million - $1.63 Million	89,454 Added 177.23%	139,926 $2.43 Million
Q3 2018 Oct 26, 2018	SELL	$13.63 - $15.7 $124,305 - $143,184	-9,120 Reduced 15.3%	50,472 $773,000
Q2 2018 Aug 08, 2018	BUY	$13.44 - $17.59 $724,147 - $947,749	53,880 Added 943.28%	59,592 $821,000
Q1 2018 May 11, 2018	SELL	$13.8 - $16.99 $31,574 - $38,873	-2,288 Reduced 28.6%	5,712 $95,000
Q4 2017 Feb 06, 2018	BUY	$11.73 - $14.75 $43,025 - $54,103	3,668 Added 84.67%	8,000 $114,000
Q3 2017 Nov 07, 2017	BUY	$12.06 - $14.12 $52,243 - $61,167	4,332	4,332 $61,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

79M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.34B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Innoviva, Inc. Transaction History